PATENT CLAIM ANALYSIS

Application Number: 15894724
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "657000"]

Abstract:
A composition for the treatment of emesis comprising 8-hydroxy-2-(dipropylamino)tetralin in which the ratio of the S enantiomer of the 8-hydroxy-2-(dipropylamino)tetralin to the R enantiomer of the 8-hydroxy-2-(dipropylamino)tetralin is between 2:1 and 10:1, and a method of treating or preventing emesis with such a composition.

Claim (Index 1):
A composition comprising 8-hydroxy-2-(dipropylamino)tetralin, wherein the ratio of the S enantiomer of the 8-hydroxy-2-(dipropylamino)tetralin to the R enantiomer of the 8-hydroxy-2-(dipropylamino)tetralin is between 2:1 and 10:1.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 88.0
- Lexical Diversity: 1.70588
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13274106', '14337037', '12692128', '09985679', '10438477']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7342858573861762
- 35 USC 102 Novelty (BERT): 0.5102043183359627
- Combined Prediction Score: 0.7118777034811549
- Mean Citation Score: 191.814464
- Max Citation Score: 231.29924
- Similarity Product: 134.90132180343628

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test